U.S. Exosomes Market Size & Outlook, 2026-2033
- Biotechnology
- RNA analysis
- Exosomes Market Outlook
- RNA analysis
Global Market
Related Markets
Ask Prism AI anything about the exosomes market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
U.S. exosomes market highlights
- The U.S. exosomes market generated a revenue of USD 92.2 million in 2024 and is expected to reach USD 442.1 million by 2030.
- The U.S. market is expected to grow at a CAGR of 30.2% from 2025 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2024.
- Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Exosomes market data book summary
| Market revenue in 2024 | USD 92.2 million |
| Market revenue in 2030 | USD 442.1 million |
| Growth rate | 30.2% (CAGR from 2025 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Kits & Reagents |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Instruments, Services |
| Key market players worldwide | Danaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio |
Other key industry trends
- In terms of revenue, U.S. accounted for 52.0% of the global exosomes market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. exosomes market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 442.1 million by 2030.
Exponential growth in the number of exosomes research projects in the U.S. has encouraged the entry of new market players in the region. For instance, in November 2015, University of Texas MD Anderson Cancer Center established Codiak Bio Sciences in collaboration with Broad Institute of MIT and Harvard University.
Another factor anticipated to contribute to the growth of the U.S. market is the ongoing IP-related activities in this country pertaining to the development of exosomes applications. For instance, in December 2016, Creative Medical Technology Holdings announced the filing of a U.S.
Patent application titled Treatment of Stroke by Amniotic Fluid Derived Stem Cell Conditioned Media and Products Derived There of. This patent application covers the usage of the company Amnio Stem stem cell for the production of exosomes that can regenerate damaged brain tissues after stroke.
No credit card required*
Publish Date: May 05, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Exosomes Market Scope
Exosomes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| FUJIFILM Holdings Corp | View profile | 83,784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | www.fujifilmholdings.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| Abcam PLC | View profile | 1,760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | www.abcam.com |
| Miltenyi Biotec | View profile | 1001-5000 | Bergisch Gladbach, Nordrhein-Westfalen, Germany, Europe | www.miltenyibiotec.com |
| RoosterBio | View profile | 1-10 | Frederick, Maryland, United States, North America | roosterbio.com |
U.S. Exosomes Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Exosomes Market Outlook will help companies and investors design strategic landscapes.
Kits & Reagents was the largest segment with a revenue share of 58.89% in 2024.
Horizon Databook has segmented the U.S. exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Exponential growth in the number of exosomes research projects in the U.S. has encouraged the entry of new market players in the region. For instance, in November 2015, University of Texas MD Anderson Cancer Center established Codiak Bio Sciences in collaboration with Broad Institute of MIT and Harvard University.
Another factor anticipated to contribute to the growth of the U.S. market is the ongoing IP-related activities in this country pertaining to the development of exosomes applications. For instance, in December 2016, Creative Medical Technology Holdings announced the filing of a U.S.
Patent application titled Treatment of Stroke by Amniotic Fluid Derived Stem Cell Conditioned Media and Products Derived There of. This patent application covers the usage of the company Amnio Stem stem cell for the production of exosomes that can regenerate damaged brain tissues after stroke.
- U.S. Exosomes Market Workflow Outlook (Revenue, USD Million , 2021-2033)
- Isolation Methods
- Downstream Analysis
- U.S. Exosomes Market Product Outlook (Revenue, USD Million , 2021-2033)
- Kits & Reagents
- Instruments
- Services
- U.S. Exosomes Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals & diagnostics centers
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- U.S. Exosomes Market Application Outlook (Revenue, USD Million , 2021-2033)
- Neurodegenerative diseases
- Cardiovascular diseases
- Others
- Cancer
- Infectious diseases
Reasons to subscribe to Exosomes Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Exosomes Market Outlook databook
- Our clientele includes a mix of Exosomes Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Exosomes Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Exosomes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Exosomes Market, 2021-2033 (US$M)
U.S. exosomes market statistics, by workflow, 2021-2033 (US$M)
